CH EMED EPR
2.0.0 - trial-use Switzerland flag

This page is part of the FHIR eMedication exchange formats for the implementation effort of CARA within its EPR community (v2.0.0: STU2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Resource Profile: CHEMEDEPRMedicationStatement - Examples

Draft as of 2025-01-21

Examples for the ch-emed-epr-medicationstatement-treatmentplan Profile.

MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with max dose per period
MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with split dose
MedicationStatement: Paracetamol Axapharm (MTP)
MedicationStatement: Paracetamol Dafalgan Effervescent (MTP)
MedicationStatement: Triatec (MTP)